期刊文献+

皮肤基底细胞癌T钙黏蛋白的表达及其DNA异常甲基化分析 被引量:2

The expression and aberrant methylation of T-cadherin in cutaneous basal cell carcinoma
原文传递
导出
摘要 目的 检测皮肤基底细胞癌(BCC)中T钙黏蛋白的表达以及异常甲基化。方法 采用免疫组化法和CpG岛甲基化特异性PCR方法。对29例BCC和19例正常人暴光部位皮肤的组织标本进行T钙黏蛋白的表达及甲基化检测。结果 正常皮肤皆表达T钙黏蛋白,29例BCC中8例(27.59%)检测到T钙黏蛋白表达(P〈0.05),9例BCC(31.03%)和19例正常皮肤中的1例(5.26%)检测到T钙黏蛋白启动子区域的异常甲基化(P〈0.05)。结论 T钙黏蛋白表达降低与皮肤基底细胞癌的发病机制相关,T钙黏蛋白启动子区域的异常甲基化与蛋白低表达可能相关。 Objective To detect the expression and aberrant methylation of T-cadherin in cutaneous basal cell carcinoma ( BCC ). Methods Skin tissues were resected during operation in light-exposed sites from 29 patients with BCC and 19 normal controls. The expression and aberrant methylation of T-cadherin were tested by immunohistochemical staining and methylation-specific polymerase chain reaction ( MSP ), respectively. Results Immunohistochemical staining showed that T-cadherin was expressed in 8 of 29 (27.59%) BCC specimens, whereas in all ( 100% ) normal controls, and there was a significant difference in T-cadherin positivity rates between the two groups (χ^2 = 24.46, P 〈 0.05 ). The aberrant methylation of T-cadherin promoter region was detected in 9 BCC ( 37.93% ) and in 1 ( 5.26% ) control specimen with significant difference between them (χ^2 = 4.62, P 〈 0.05 ). Conclusion The decrease of T-cadherin expression, likely to be relavent to the aberrant methylation of T-cadberin promoter, might contribute to the pathogenesis of BCC.
出处 《中华皮肤科杂志》 CAS CSCD 北大核心 2007年第3期152-154,共3页 Chinese Journal of Dermatology
基金 广东省卫生厅资助课题(A2004627)
关键词 鳞状细胞 甲基化 钙粘着糖蛋白类 Carcinoma, basal cell Methylation Cadherins
  • 相关文献

参考文献11

  • 1Zhou S, Matsuyoshi N, Liang SB, et al. Expression of T-cadherin in basal keratinocytes of skin. J Invest Dermatol, 2002, 118(6):1080-1084.
  • 2Takeuchi T, Misaki A, Fujita J, et al. T-cadherin (CDH13, H-cadherin) expression downregulated surfactant protein D in bron-chioloalveolar cells. Virchows Arch, 2001, 438(4): 370-375.
  • 3Takeuchi T, Ohtsuki Y. Recent progress in T-cadherin (CDH13,H-cadherin) research. Histol Histopathol, 2001, 16(4): 1287-1293.
  • 4Kawakami M, Stanb J, Cliby W, et al. Involvement of H-cadherin(CDH13) on 16q in the region of frequent deletion in ovarian cancer. Int J Oncol, 1999, 15(4): 715-720.
  • 5Maruyama R, Toyooka S, Toyooka KO, et al. Aberrant promoter methylation profile of bladder cancer and its relationship to clini-copathological features. Cancer Res, 2001, 61 (24): 8659-8663.
  • 6Toyooka KO, Toyooka S, Virmani AK, et al. Loss of expression and aberrant methylation of the CDH13 (H-cadherin) gene in breast and lung carcinomas. Cancer Res, 2001, 61(11): 4556-4560.
  • 7Pizarro A. E-cadherin expression is frequently reduced in infil-trative basal cell carcinoma. J Dermatol, 2000, 27( 12): 804-805.
  • 8Jones PA, Gonzalgo ML. Altered DNA methylation and genome instability: a new pathway to cancer? Proc Nail Acad Sci U S A,1997, 94(6): 2103-2105.
  • 9Sato M, Mori Y, Sakurada A, et al. The H-cadherin (CDH13)gene is inactivated in human lung cancer. Hum Genet, 1998, 103(1): 96-101.
  • 10Lee SW, Reimer CL, Campbell DB, et al. H-cadherin expression inhibits in vitro invasiveness and tumor formation in vivo. Car-cinogenesis, 1998, 19(6): 1157-1159.

同被引文献18

  • 1Makrilia N, Kollias A, Manolopoulos L, et al. Cell adhesion molecues: role and clinical significance in cancer. Cancer Invest, 2009, 27: 1023-1037.
  • 2Blaschuk OW, Devemy E. Cadherins as novel targets for anti-cancer therapy. Eur J Pharmacol, 2009, 625: 195-198.
  • 3Angst BD, Marcozzi C, Magee AL. The T-cadherin superfamily: diversity in from and function. J Cell Sci, 2001, 114: 629-641.
  • 4Zhong Y, Delgado Y, Gomez J, et al. Loss of H-cadherin protein expression in human non-small cell lung cancer is associated with tumorigenicity. Clin Cancer Res, 2001,7 : 1683-1687.
  • 5Takeuchi T, Liang SB, Matsuyoshi N, et al. Loss of T-cadherin (CDH13, H-cadherin) expression in cutaneous squamous cell carcinoma. Laboratory Investigation. 2002, 82: 1023-1029.
  • 6Andreeva AV, Kutuzov MA. Cadherin 13 in cancer. Genes Chromosomes Cancer, 2010, 49: 775-790.
  • 7Jin Z, Cheng Y, Olaru A, et al. Promoter hypermethylation of CDH13 is a common, early event in human esophageal adenocarcinogenesis and correlates with clinical risk factors, lnt J Cancer, 2008, 123 : 2331-2336.
  • 8Feng Q, Hawes SE, Stern JE, et al. DNA methylation in tumor and matched normal tissues from non-small cell lung cancer patients. Cancer Epidemiol Biomarkers Prey, 2008, 17 : 645-654.
  • 9Chan DW, Lee JM, Chan PC, et al. Genetic and epigenetic inactivation of T-cadherin in human hepatocellular carcinoma cells. Int J Cancer, 2008, 123: 1043-1052.
  • 10Deng T, Zhang Y. 5-Aza-2'-deoxycytidine reactivates expression of RUNX3 by deletion of DNA methyltransferases leading to caspase independent apoptosis in colorectal cancer Lovo cells. Biomed Pharmacother, 2009, 63: 492-500.

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部